BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 2293858)

  • 1. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers.
    Ohyama S; Yonemura Y; Miyazaki I
    Cancer; 1990 Jan; 65(1):116-21. PubMed ID: 2293858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Flow cytometric cell cycle analysis using a monoclonal antibody to bromodeoxyuridine on gastric cancers].
    Ohyama S; Yonemura Y; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1848-54. PubMed ID: 2608014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proliferative activity as a marker for lymph node metastases on early gastric cancers--in vitro bromodeoxyuridine labeling for clinical use].
    Ohyama S; Yonemura Y; Kamata T; Kosaka T; Yamaguchi A; Kouichi ; Miwa ; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):354-9. PubMed ID: 2359392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
    Wu YF; Xu HM; Chen JQ
    Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of DNA ploidy and proliferative activity in human gastric cancer.
    Yonemura Y; Sugiyama K; Fujimura T; De Aretxabala X; Kamata T; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
    Cancer; 1988 Oct; 62(8):1497-502. PubMed ID: 3167767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer.
    Salud A; Porcel JM; Raikundalia B; Camplejohn RS; Taub NA
    J Surg Oncol; 1999 Nov; 72(3):167-74. PubMed ID: 10562364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignancy in gastric carcinoma, with special reference to the DNA ploidy and proliferative activity].
    Yonemura Y; Sugiyama K; Kamata T; Fujimura T; Yamaguchi A; Miwa K; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1175-80. PubMed ID: 3054478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma.
    Yonemura Y; Ooyama S; Sugiyama K; Kamata T; De Aretxabala X; Kimura H; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
    Cancer Res; 1990 Feb; 50(3):509-14. PubMed ID: 2297693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
    Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
    Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of DNA ploidy and clinical outcome in early gastric carcinomas.
    Yonemura Y; Sugiyama K; Kamata T; Kosaka T; Yamaguchi A; Miwa K; De Aretxeblala X; Miyazaki I
    Oncology; 1990; 47(1):49-54. PubMed ID: 2300385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.
    Yokoe T; Izuo M; Ishida T; Iino Y; Kawai T
    Jpn J Surg; 1990 Sep; 20(5):491-7. PubMed ID: 2243441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer.
    Eskelinen M; Nordling S; Puittinen J; Pesonen E; Collan Y
    Pathol Res Pract; 1989 Nov; 185(5):694-7. PubMed ID: 2626377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE; André S; Soares J
    J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
    J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators.
    Malmström H; Schmidt H; Persson PG; Carstensen J; Nordenskjöld B; Simonsen E
    Gynecol Oncol; 1992 Feb; 44(2):172-7. PubMed ID: 1544595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
    Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
    Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma.
    Victorzon M; Roberts PJ; Haglund C; von Boguslawsky K; Nordling S
    Oncology; 1996; 53(3):182-91. PubMed ID: 8643219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DNA ploidy pattern in diffuse infiltrating carcinomas of the stomach].
    Yonemura Y; Sugiyama K; Kamata T; Fujimura T; Yamaguchi A; Miwa K; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1989 May; 90(5):681-5. PubMed ID: 2796943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
    Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
    Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
    Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.